FDA Center for Drug Evaluation & Research Issues Warning Letter to Peptide Partners
September 02, 2026
September 02, 2026
WASHINGTON, Sept. 2 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Peptide Partners LLC from its Center for Drug Evaluation and Research:
* * *
Recipient: Zachary David Hoff, Peptide Partners LLC, 8350 Bee Ridge, #379, Sarasota, FL 34241-9607, United States, support@peptide.partners, (b)(6), (b)(7)(C)
Issuing Office: Center for Drug Evaluation and Research (CDER) United States
* * *
Recipient: Zachary David Hoff, Peptide Partners LLC, 8350 Bee Ridge, #379, Sarasota, FL 34241-9607, United States, support@peptide.partners, (b)(6), (b)(7)(C)
Issuing Office: Center for Drug Evaluation and Research (CDER) United States
